Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Glaucoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Glaukos Investigative Site, Grand Junction, Colorado, United States
Glaukos Investigative Site, Oklahoma City, Oklahoma, United States
Glaukos Clinical Site, El Paso, Texas, United States
Study leads
Luis G. Vargas, MD
Study Chair
Glaukos Corporation